Cèlia Rodríguez-Borjabad

Author

Institut d'Investigació Sanitària Pere Virgili ORCID

Also Known As

C. Borjabad-Rodríguez, C. Rodríguez Borjabad, C. Rodríguez-Borjabad, Celia Rodríguez Borjabad, Celia Rodríguez-Borjabad, Cèlia Rodríguez-Borjabad

Publications

791

Citations

H-Index

Concepts

All Affiliations

Institut d'Investigació Sanitària Pere Virgili Hospital Universitari Sant Joan de Reus Universitat Rovira i Virgili Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition

About

Cèlia Rodríguez-Borjabad is an author at Institut d'Investigació Sanitària Pere Virgili specializing in medicine, atherosclerosis, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	111
2	Public Health	4	4	112
3	Natural Sciences	1	1	13
4	Biochemistry	1	1	13
5	Child Development	1	1	28

Cèlia Rodríguez-Borjabad

Publications

627

Citations

H-Index

Page 1

	Year	Citations
Low HDL and high triglycerides predict COVID-19 severity L. Masana, Eudald Correig, Daiana Ibarretxe, Scientific Reports	2021	192
HDL Triglycerides: A New Marker of Metabolic and Cardiovascular Risk Josefa Girona, Núria Amigó, Daiana Ibarretxe, International Journal of Molecular Sciences	2019	99
Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients L. Masana, Eudald Correig, Cèlia Rodríguez-Borjabad, European Heart Journal - Cardiovascular Pharmacotherapy	2020	85
The Circulating GRP78/BiP Is a Marker of Metabolic Diseases and Atherosclerosis: Bringing Endoplasmic Reticulum Stress into the Clinical Scenario Josefa Girona, Cèlia Rodríguez-Borjabad, Daiana Ibarretxe, Journal of Clinical Medicine	2019	62
Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society María José Ariza, José Rioja, Daiana Ibarretxe, Journal of clinical lipidology Metabolic SyndromeFamilial Chylomicronemia SyndromeEpidemiologyLipid DisorderCardiovascular Disease	2018	43
Detecting familial hypercholesterolemia earlier in life by actively searching for affected children:The DECOPIN project Daiana Ibarretxe, Cèlia Rodríguez-Borjabad, Albert Feliu, Atherosclerosis Decopin ProjectFamilial HypercholesterolemiaLipid DisorderChild HealthGenetic Epidemiology	2018	28
Plasma inducible degrader of the LDLR, soluble low-density lipoprotein receptor, and proprotein convertase subtilisin/kexin type 9 levels as potential biomarkers of familial hypercholesterolemia in children Josefa Girona, Cèlia Rodríguez-Borjabad, Daiana Ibarretxe, Journal of clinical lipidology Familial HypercholesterolemiaPlasma Inducible DegraderCardiovascular DiseaseBiomarkersHyperlipidemia	2017	22
Glycoprotein Profile Assessed by 1H-NMR as a Global Inflammation Marker in Patients with HIV Infection. A Prospective Study Ana Irene Malo, Anna Rull, Josefa Girona, Journal of Clinical Medicine	2020	20
Dietary intake and lipid levels in Norwegian and Spanish children with familial hypercholesterolemia Cèlia Rodríguez-Borjabad, Ingunn Narveud, Jacob J. Christensen, Nutrition Metabolism and Cardiovascular Diseases ObesityNutritionLipid DisorderNutritional EpidemiologyCardiovascular Disease	2020	19
Women with familial hypercholesterolemia phenotype are undertreated and poorly controlled compared to men Alberto Zamora, Rafel Ramos, Marc Comas‐Cufí, Scientific Reports	2023	17

Page 1